China’s National Development and Reform Commission (NDRC) ordered price cuts on 82 different drugs in 400 formulations, most of them from foreign drugmakers, by an average of 14% starting September 1. The drugs were described as being hormone, endocrine and nerve system medications. Many of the drugs were medications that previously enjoyed freedom to set their own prices because of their innovative nature. More details....

Share this with colleagues: